Tecogen IncTGEN
Price$2.65Intrinsic value$1.2155% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $24.6M+8.7% YoYTTM through 30 Jun 2026
Net Income -$10.4MTTM through 30 Jun 2026
Free Cash Flow -$11.8MTTM through 30 Jun 2026

Margins

Current
Gross Margin40.9%
EBITDA Margin-38.6%
Operating Margin-33.7%
Net Margin-42.3%

Returns

-49.7%ROE
-32.9%ROA

Balance Sheet Health

Debt / Equity0.07x
Current Ratio3.02x
Net Debt-$7.9Mnet cash position
Cash & Equivalents$6.8M

Quality Metrics

Altman Z-Score1.89
Piotroski F-Score1 / 9
FCF Margin-48.2%
Rule of 40-34.9
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $27.1M
Diluted EPS-$0.36TTM
'18'20'21'22'23'24'25
FY2025: $-0.30

Dividend

No dividend

Capital Allocation

R&D Spend$1.3M
Capex Intensity1.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.